Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.88
Delayed Data
As of Jul 25
 +0.084 / +1.24%
Today’s Change
5.60
Today|||52-Week Range
11.40
-8.69%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.80
Today’s open6.76
Day’s range6.76 - 6.88
Volume1,575
Average volume (3 months)5,383
Market cap$28.4M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio19.5
Price/Sales2.32
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
CLSNCelsion Corp+0.05+4.13%
CURNeuralstem Inc-0.01-2.93%
VTGNVistaGen Therapeutic...-0.06-1.71%
CANFCan Fite Biopharma L...+0.04+1.91%
Data as of 07/25/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

Partner Offers

Search for Jobs